For details see Note (34) “Equity”.
€ million |
|
Equity capital |
|
Capital reserves |
|
Retained earnings |
|
Gains/losses recognized in equity |
|
Equity attributable to shareholders of Merck KGaA, Darmstadt, Germany |
|
Non-controlling interests |
|
Total equity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 1, 2021 |
|
565 |
|
3,814 |
|
12,378 |
|
189 |
|
16,946 |
|
71 |
|
17,017 |
Profit after tax |
|
– |
|
– |
|
3,055 |
|
– |
|
3,055 |
|
10 |
|
3,065 |
Gains/losses recognized in equity |
|
– |
|
– |
|
599 |
|
1,635 |
|
2,234 |
|
5 |
|
2,239 |
Comprehensive income |
|
– |
|
– |
|
3,653 |
|
1,635 |
|
5,289 |
|
15 |
|
5,304 |
Dividend payments |
|
– |
|
– |
|
-181 |
|
– |
|
-181 |
|
-8 |
|
-189 |
Profit transfer to/from E. Merck KG, Darmstadt, Germany, including changes in reserves |
|
– |
|
– |
|
-716 |
|
– |
|
-716 |
|
– |
|
-716 |
Transactions with no change of control |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
Change in scope of consolidation/Other |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
Dec. 31, 2021 |
|
565 |
|
3,814 |
|
15,134 |
|
1,824 |
|
21,338 |
|
78 |
|
21,416 |
€ million |
|
Equity capital |
|
Capital reserves |
|
Retained earnings |
|
Gains/losses recognized in equity |
|
Equity attributable to shareholders of Merck KGaA, Darmstadt, Germany |
|
Non-controlling interests |
|
Total equity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 1, 2022 |
|
565 |
|
3,814 |
|
15,134 |
|
1,824 |
|
21,338 |
|
78 |
|
21,416 |
Profit after tax |
|
– |
|
– |
|
3,326 |
|
– |
|
3,326 |
|
14 |
|
3,339 |
Gains/losses recognized in equity |
|
– |
|
– |
|
1,109 |
|
1,261 |
|
2,370 |
|
-2 |
|
2,368 |
Comprehensive income |
|
– |
|
– |
|
4,435 |
|
1,261 |
|
5,696 |
|
12 |
|
5,708 |
Dividend payments |
|
– |
|
– |
|
-239 |
|
– |
|
-239 |
|
-11 |
|
-251 |
Profit transfer to/from E. Merck KG, Darmstadt, Germany, including changes in reserves |
|
– |
|
– |
|
-868 |
|
– |
|
-868 |
|
– |
|
-868 |
Transactions with no change of control |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
Change in scope of consolidation/Other |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
Dec. 31, 2022 |
|
565 |
|
3,814 |
|
18,463 |
|
3,086 |
|
25,927 |
|
78 |
|
26,005 |